Differential expression of lymphokine-activated killer cells and natural killer cells in adoptive transfer experiments utilizing fractionated bone marrow.
Open Access
- 15 October 1986
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 137 (8) , 2425-2427
- https://doi.org/10.4049/jimmunol.137.8.2425
Abstract
Precursors of murine natural killer (NK) cells and lymphokine-activated killer (LAK) cells can be distinguished by utilizing an adoptive transfer system in which donor bone marrow is fractionated on Percoll discontinuous gradients. Although precursors of LAK cells are present in all fractions, one fraction (greater than 65% Percoll) contains LAK precursors and is depleted of NK precursors. Both in vitro NK activity and in vivo hybrid resistance is abrogated in recipients of bone marrow from the greater than 65% Percoll fraction, whereas LAK activity can be readily demonstrated.This publication has 10 references indexed in Scilit:
- Similarities and distinctions between murine natural killer cells and lymphokine-activated killer cellsCellular Immunology, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- Evidence that lymphokine-activated killer cells and natural killer cells are distinct based on an analysis of congenitally immunodeficient mice.The Journal of Immunology, 1985
- Comparison of murine lymphokine-activated killer cells, natural killer cells, and cytotoxic T lymphocytesCellular Immunology, 1985
- Lymphokine-activated killer cells are generated before classical cytotoxic T lymphocytes after bone marrow transplantation in mice.The Journal of Immunology, 1985
- Stimulation of genetic resistance to marrow grafts in mice by interferon-alpha/beta.The Journal of Immunology, 1985
- LYSIS OF SPONTANEOUS MURINE BREAST-TUMORS BY HUMAN INTERLEUKIN-2-STIMULATED SYNGENEIC LYMPHOCYTES-T1985
- Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2Science, 1984
- Generation of nonspecific murine cytotoxic T cells in vitro by purified human interleukin 2Cellular Immunology, 1984
- Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cellsThe Journal of Experimental Medicine, 1983